CAC2 Childhood Cancer Community News Digest (August 21-27)
Assorted News from the Last Week:
Use of homoharringtonine (HHT) may result in improved responses among patients with pediatric acute myeloid leukemia (AML) compared with etoposide-based induction therapy, according to findings from a study published in the Journal of Clinical Oncology.
Researchers at Texas A&M University announced a project to explore the use of 3D printing technology to produce customized pharmaceutics for pediatric patients.
The National Comprehensive Cancer Network® today announced the publication of NCCN Guidelines for Patients®: Hodgkin Lymphoma in Children.
Upcoming Webinars, Online Opportunities, and Meetings:
Triage Cancer will offer a webinar on Medicare 101 on September 13 at 1:00 ET about Learn about the different “Parts” of Medicare, supplemental plans, decisions to make during open enrollment, and how it works with other insurance. We’ll close with a hands-on workshop to compare Medicare plans using Triage Cancer’s Medicare Options Comparison Worksheet.. Learn more and register.
Zoefia Alexandria Green Heart Gala, beautiful night of elegance and celebration to raise funds and awareness for Childhood Cancer/ Brain Cancer, September 15 at 7:00 pm ET. Learn more and register.
The co-chairs of the Congressional Childhood Cancer Caucus will host the 14th Annual Childhood Cancer Summit on Thursday, September 21, 2023 in Washington, D.C. Everyone is invited. All RSVPs should be directed to McKayla Montgomery at .
Registration for CureFest 2023 is now open! Register today at: www.curefestusa.org
MyPART will partner with the Life Raft Group to hold the NIH Pediatric and Wild-Type GIST Clinicat the NIH Clinical Center in Bethesda, MD. The clinic brings patients and families together with expert clinicians and researchers. To learn more about the upcoming clinic, please email BJ Thomas, RN at .
Register for the 55th SIOP in Ottawa, Canada on October 11-14. Experience 4 outstanding days of cutting-edge science, engaging debates, and networking with world-renowned experts. Learn more and register.
Recent Recordings:
Jordan Hansford, MD, clinical lead, Neuro-Oncology Group, Royal Children’s Hospital Melbourne, discusses the phase 2 FIREFLY-1 trial (NCT04775485), which is investigating the pan-RAF inhibitor tovorafenib (DAY101) in children and young adults patients with low-grade glioma.
Take Action:
Pediatric Cancer legislation needs your support. Learn more about how to support the Gabriella Miller Kids First Research Act 2.0, the Sawyer Finn ACT, Comprehensive Cancer Survivor Act, Accelerating Kids’ Access to Care Act,and the Give Kids a Chance Act.
Submit your child’s photo for the CureFest Tribute Wall.
To help spread the word about the Childhood Cancer Data Initiative (CCDI), the National Cancer Institute has created a communications toolkit with a CCDI overview flyer, a one-pager with frequently asked questions about the CCDI Data Ecosystem, and sample social media posts and graphics. Access the toolkit, and feel free to reference, copy, and use its content for inspiration.
SUBSCRIBE
Sign up to receive a copy of CAC2's free childhood cancer news digest in your inbox each week.
Categories
- Blog Posts (98)
- Explainer Post (12)
- Guest Blogs (16)
- Member Blogs (40)
- Survivorship Matters Blog (9)
- CAC2 News (25)
- Collaborative Achievements (14)
- Community News (258)
- In Memoriam (2)
- News Digest (207)
- Webinars (64)